Cargando…
Cannabidiol markedly alleviates skin and liver fibrosis
Cannabidiol (CBD) has been suggested as a potential therapy for inflammatory and fibrotic diseases. Cannabidiol was demonstrated to reduce alcohol-induced liver inflammation and steatosis but its specific activity on the fibrotic process was not investigated. Herein, the antifibrotic effects of cann...
Autores principales: | del Río, Carmen, Ruiz-Pino, Francisco, Prados, María E., Fiebich, Bernd L., Tena-Sempere, Manuel, Muñoz, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627610/ https://www.ncbi.nlm.nih.gov/pubmed/36339540 http://dx.doi.org/10.3389/fphar.2022.981817 |
Ejemplares similares
-
Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023) -
Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
por: Souza, José Diogo S., et al.
Publicado: (2022) -
Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021) -
Anti-Inflammatory and Anti-Oxidative Effects of AM404 in IL-1β-Stimulated SK-N-SH Neuroblastoma Cells
por: Apweiler, Matthias, et al.
Publicado: (2021) -
Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
por: Martínez-Orgado, José, et al.
Publicado: (2021)